Medical Equipment Donated to Haiti Disaster Relief
|
By LabMedica International staff writers Posted on 17 Feb 2010 |
Immediately following the January 12, 2010, earthquake, Siemens Healthcare (Erlangen, Germany) mobilized to provide disaster relief assistance to the citizens of Haiti. The Healthcare Sector of Siemens AG has shipped healthcare systems and supplies through Project HOPE (Millwood, VA, USA) to aid healthcare workers in their efforts to help the victims.
Siemens Healthcare has donated 20 Acuson P10 ultrasound systems. These handheld systems are well suited for the urgent medical needs in Haiti as they were designed for triage and emergency situations and provide physicians and emergency personnel with earlier, faster, and more accurate clinical assessment in seconds. The system provides Focused Abdominal Sonography for Trauma (FAST) protocols, which can identify free fluid from organ ruptures due to blunt trauma and identify foreign objects lodged inside the body. The unit runs on battery power, and will scan continuously for one hour with one charge. An average scan in disaster type conditions only takes minutes. Because of its pocket-sized design and lightweight of only 0.73 kg, the Acuson P10 system is especially useful in the cramped and difficult working conditions in Haiti.
Siemens donated 10 RAPIDPoint 350 blood gas analyzers to Project HOPE. These systems can be used to provide critical care blood gas and blood electrolyte-test results within minutes in a field hospital setting. With these blood gas analyzers, Siemens provided sufficient test systems and supplies to perform 90,000 tests and worked with their partner, Smiths Medical (London, UK), who also donated sterile blood sample syringes necessary to perform the tests.
Moreover, Siemens donated enough Multistix 10 SG urinalysis strips to perform 90,000 urine tests. These test strips assist rapid diagnosis in kidney function, urinary tract infections, carbohydrate metabolism, and liver function.
The Siemens technical team will be available by telephone to support Project HOPE as needed in the set up and operation of the systems.
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology, and hearing aids.
Founded in 1958, Project HOPE (Health Opportunities for People Everywhere) is dedicated to providing lasting solutions to health problems with the mission of helping people to help themselves. Identifiable to many by the SS HOPE, the world's first peacetime hospital ship, Project HOPE now provides medical training and health education, as well as conducts humanitarian assistance programs in more than 35 countries.
Related Links:
Siemens Healthcare
Project HOPE
Siemens Healthcare has donated 20 Acuson P10 ultrasound systems. These handheld systems are well suited for the urgent medical needs in Haiti as they were designed for triage and emergency situations and provide physicians and emergency personnel with earlier, faster, and more accurate clinical assessment in seconds. The system provides Focused Abdominal Sonography for Trauma (FAST) protocols, which can identify free fluid from organ ruptures due to blunt trauma and identify foreign objects lodged inside the body. The unit runs on battery power, and will scan continuously for one hour with one charge. An average scan in disaster type conditions only takes minutes. Because of its pocket-sized design and lightweight of only 0.73 kg, the Acuson P10 system is especially useful in the cramped and difficult working conditions in Haiti.
Siemens donated 10 RAPIDPoint 350 blood gas analyzers to Project HOPE. These systems can be used to provide critical care blood gas and blood electrolyte-test results within minutes in a field hospital setting. With these blood gas analyzers, Siemens provided sufficient test systems and supplies to perform 90,000 tests and worked with their partner, Smiths Medical (London, UK), who also donated sterile blood sample syringes necessary to perform the tests.
Moreover, Siemens donated enough Multistix 10 SG urinalysis strips to perform 90,000 urine tests. These test strips assist rapid diagnosis in kidney function, urinary tract infections, carbohydrate metabolism, and liver function.
The Siemens technical team will be available by telephone to support Project HOPE as needed in the set up and operation of the systems.
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology, and hearing aids.
Founded in 1958, Project HOPE (Health Opportunities for People Everywhere) is dedicated to providing lasting solutions to health problems with the mission of helping people to help themselves. Identifiable to many by the SS HOPE, the world's first peacetime hospital ship, Project HOPE now provides medical training and health education, as well as conducts humanitarian assistance programs in more than 35 countries.
Related Links:
Siemens Healthcare
Project HOPE
Latest Clinical Chem. News
- Saliva-Based Test Detects Biochemical Signs of Sleep Loss
- Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
- Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
- Urine-Based Test Shows Promise for Autism Screening in Children
- Blood-Based Sensor Detects Early Signs of Alzheimer’s and Parkinson’s
- Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis
- Urine-Based Alzheimer’s Test Receives FDA Breakthrough Device Designation
- Fluid Biomarker Improves Diagnosis and Monitoring of Primary CNS Lymphoma
- New CA19-9 Cutoff Value Helps Identify High-Risk Pancreatic Cancer Patients
- Blood-Based Biomarkers Show Promise for Psychosis Risk Prediction
- International Experts Recommend Ending Routine 'Corrected' Calcium Reporting
- Long-Term Data Show PSA Screening Modestly Reduces Prostate Cancer Deaths
- Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively
- FDA-Cleared Assay Enables Comprehensive Automated Testosterone Testing
- CE-Marked Blood Biomarker Test Advances Automated Alzheimer’s Diagnostics
- Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection
Channels
Clinical Chemistry
view channel
Saliva-Based Test Detects Biochemical Signs of Sleep Loss
Acute sleep loss impairs cognition and motor skills, raising safety risks that resemble alcohol intoxication. Clinicians currently lack an objective biochemical test to determine when someone is dangerously... Read more
Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
Alzheimer’s disease is typically confirmed and staged with positron emission tomography scans and cerebrospinal fluid testing, procedures that are costly and invasive. Broader access to minimally invasive... Read more
Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
Blood-based screening for Alzheimer’s disease offers a noninvasive, lower-cost alternative to brain imaging or spinal fluid testing, yet its ability to flag the earliest cognitive changes has been unclear.... Read moreMolecular Diagnostics
view channel
New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance
Rapid identification of Ebola infections is essential to limit transmission and guide public health response, yet detection can be difficult when outbreaks involve rare variants. The current outbreaks... Read more
Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead
Lung cancer remains a leading cause of cancer death, and many cases are detected only after symptoms appear. Current screening programs largely target people with a history of smoking, leaving other at-risk... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read more
Automated Blood Culture System Speeds Detection of Bloodstream Infections
Bloodstream infections and sepsis require rapid laboratory detection to guide targeted antimicrobial therapy and reduce mortality. Conventional blood culture workflows can delay actionable results by critical... Read morePathology
view channel
3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read more
Blood-Based Method Tracks Gene Activity in the Living Brain
Real-time measurement of gene activity in the brain has been limited by assays requiring destructive tissue sampling. Tracking active genes could reveal how the body responds to environmental factors,... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer
Natera, Inc. (Austin, TX, USA) and CytoDyn Inc. (Vancouver, WA, USA) announced a strategic collaboration focused on metastatic colorectal cancer (mCRC). Under the agreement, Natera will evaluate circulating... Read more








